199 related articles for article (PubMed ID: 15210993)
1. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding.
Huai Q; Wang H; Zhang W; Colman RW; Robinson H; Ke H
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9624-9. PubMed ID: 15210993
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity.
Huai Q; Liu Y; Francis SH; Corbin JD; Ke H
J Biol Chem; 2004 Mar; 279(13):13095-101. PubMed ID: 14668322
[TBL] [Abstract][Full Text] [Related]
3. Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7.
Wang H; Liu Y; Chen Y; Robinson H; Ke H
J Biol Chem; 2005 Sep; 280(35):30949-55. PubMed ID: 15994308
[TBL] [Abstract][Full Text] [Related]
4. Implications of PDE4 structure on inhibitor selectivity across PDE families.
Ke H
Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
[TBL] [Abstract][Full Text] [Related]
5. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity.
Scapin G; Patel SB; Chung C; Varnerin JP; Edmondson SD; Mastracchio A; Parmee ER; Singh SB; Becker JW; Van der Ploeg LH; Tota MR
Biochemistry; 2004 May; 43(20):6091-100. PubMed ID: 15147193
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity.
Wang H; Yan Z; Yang S; Cai J; Robinson H; Ke H
Biochemistry; 2008 Dec; 47(48):12760-8. PubMed ID: 18983167
[TBL] [Abstract][Full Text] [Related]
8. [Phosphodiesterases of cyclic GMP].
Wróblewska H; Gorczyca WA
Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
[TBL] [Abstract][Full Text] [Related]
9. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of phosphodiesterase 4D and inhibitor complex(1).
Lee ME; Markowitz J; Lee JO; Lee H
FEBS Lett; 2002 Oct; 530(1-3):53-8. PubMed ID: 12387865
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis.
Huai Q; Colicelli J; Ke H
Biochemistry; 2003 Nov; 42(45):13220-6. PubMed ID: 14609333
[TBL] [Abstract][Full Text] [Related]
13. The role of tryptophan 1072 in human PDE3B inhibitor binding.
Chung C; Varnerin JP; Morin NR; MacNeil DJ; Singh SB; Patel S; Scapin G; Van der Ploeg LH; Tota MR
Biochem Biophys Res Commun; 2003 Aug; 307(4):1045-50. PubMed ID: 12878217
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity.
Huai Q; Wang H; Sun Y; Kim HY; Liu Y; Ke H
Structure; 2003 Jul; 11(7):865-73. PubMed ID: 12842049
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinity.
Zoraghi R; Corbin JD; Francis SH
J Biol Chem; 2006 Mar; 281(9):5553-8. PubMed ID: 16407275
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
17. Cyclic nucleotide phosphodiesterases: relating structure and function.
Francis SH; Turko IV; Corbin JD
Prog Nucleic Acid Res Mol Biol; 2001; 65():1-52. PubMed ID: 11008484
[TBL] [Abstract][Full Text] [Related]
18. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
[TBL] [Abstract][Full Text] [Related]
19. Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cyclic guanosine monophosphate and inhibitors.
Zoraghi R; Francis SH; Corbin JD
Biochemistry; 2007 Nov; 46(47):13554-63. PubMed ID: 17979301
[TBL] [Abstract][Full Text] [Related]
20. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity.
Xu RX; Hassell AM; Vanderwall D; Lambert MH; Holmes WD; Luther MA; Rocque WJ; Milburn MV; Zhao Y; Ke H; Nolte RT
Science; 2000 Jun; 288(5472):1822-5. PubMed ID: 10846163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
